Mayzent 2 mg film-coated tablets

DRUG3 trials

Sponsors

Antwerp University Hospital, Azienda Ospedaliera Universitaria Integrata Verona

Conditions

Active progressive multiple sclerosis course after an initial relapse clinical courseProgressive Multiple Sclerosispatients with secondary progressive MS

Phase 2

Metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration: a phase IIb triple-blind placebo-controlled randomized clinical trial (MACSiMiSE-BRAIN)

Active, not recruitingCTIS2023-503190-38-00

Antwerp University HospitalProgressive Multiple Sclerosis

Start: 2023-11-23Target: 120Updated: 2025-11-07

Phase 4

Exploring the effect of a novel therapy on chronic intrathecal inflammation in patients with active progressive multiple sclerosis

RecruitingCTIS2024-512283-65-00

Azienda Ospedaliera Universitaria Integrata Veronapatients with secondary progressive MS

Start: 2023-05-29Target: 40Updated: 2024-08-06

Effect of siponimod on relevant imaging and immunological hallmarks of progressive multiple sclerosis

RecruitingCTIS2024-518374-13-00

Azienda Ospedaliera Universitaria Integrata VeronaActive progressive multiple sclerosis course after an initial relapse clinical course

Start: 2022-02-28Target: 60Updated: 2024-11-05

Related Papers

A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial

Frontiers in Immunology2024-02-2123 citations